Specifically, KLF5 was prone to be deleted in prostate cancer (PRAD) but amplified in gastric cancer (STAD), colorectal cancer (COAD, READ), and head and neck cancer (HNSC). The gene discussed is KLF5; the disease is gastric adenocarcinoma.